Freeport-McMoran Copper & Gold Inc (FCX)vsSanofi ADR (SNY)
FCX
Freeport-McMoran Copper & Gold Inc
$57.09
+1.08%
BASIC MATERIALS · Cap: $82.05B
SNY
Sanofi ADR
$46.03
+1.97%
HEALTHCARE · Cap: $109.03B
Smart Verdict
WallStSmart Research — data-driven comparison
Sanofi ADR generates 80% more annual revenue ($46.72B vs $25.92B). SNY leads profitability with a 16.7% profit margin vs 8.5%. FCX appears more attractively valued with a PEG of 3.30. FCX earns a higher WallStSmart Score of 52/100 (C-).
FCX
Buy52
out of 100
Grade: C-
SNY
Hold49
out of 100
Grade: D+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+8.0%
Fair Value
$71.14
Current Price
$57.09
$14.05 discount
Margin of Safety
-89.7%
Fair Value
$24.79
Current Price
$46.03
$21.24 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Earnings expanding 47.7% YoY
Reasonable price relative to book value
Large-cap with strong market position
Generating 1.6B in free cash flow
Areas to Watch
Premium valuation, high expectations priced in
Distress zone — elevated risk
Weak financial health signals
Expensive relative to growth rate
2.4% earnings growth
ROE of 6.7% — below average capital efficiency
Expensive relative to growth rate
Comparative Analysis Report
WallStSmart ResearchBull Case : FCX
The strongest argument for FCX centers on Market Cap, EPS Growth.
Bull Case : SNY
The strongest argument for SNY centers on Price/Book, Market Cap, Free Cash Flow. Profitability is solid with margins at 16.7% and operating margin at 14.3%.
Bear Case : FCX
The primary concerns for FCX are P/E Ratio, Altman Z-Score, Piotroski F-Score.
Bear Case : SNY
The primary concerns for SNY are EPS Growth, Return on Equity, PEG Ratio.
Key Dynamics to Monitor
FCX profiles as a value stock while SNY is a mature play — different risk/reward profiles.
FCX carries more volatility with a beta of 1.44 — expect wider price swings.
SNY is growing revenue faster at 6.9% — sustainability is the question.
SNY generates stronger free cash flow (1.6B), providing more financial flexibility.
Bottom Line
FCX scores higher overall (52/100 vs 49/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Freeport-McMoran Copper & Gold Inc
BASIC MATERIALS · COPPER · USA
Freeport-McMoRan Inc., often called Freeport, is an American mining company based in the Freeport-McMoRan Center, in Phoenix, Arizona.
Visit Website →Sanofi ADR
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Sanofi, a healthcare company, is engaged in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company is headquartered in Paris, France.
Compare with Other COPPER Stocks
Want to dig deeper into these stocks?